"The terminology “f(Ab)” looks like a thinly-veiled reference to Lucentis/Avastin."
I agree. In the context of back of the eye diseases, what other product could it be applicable to? The big question is whether Genentech is funding or has agreed to fund any of the preclinical research. At the very least, Surmodics is making quite a display of courship to Genentech.
I would not be surprised of one of these projects was code named "Peacock" ;)
Market Data 
Markets 
AI
